Category: 109-01-3

Product Details of 109-01-3In 2020 ,《Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: Design, synthesis, biological evaluation and molecular docking study》 appeared in Bioorganic Chemistry. The author of the article were Wang, Ruifeng; Zhao, Xiangxin; Yu, Sijia; Chen, Yixuan; Cui, Hengxian; Wu, Tianxiao; Hao, Chenzhou; Zhao, Dongmei; Cheng, Maosheng. The article conveys some information:

Focal adhesion kinase (FAK) is an intracellular non-receptor tyrosine kinase responsible for development of various tumor types. Aiming to explore new potent inhibitors, two series of 2,4-disubstituted-7H-pyrrolo[2,3-d]pyrimidine derivatives were designed and synthesized on the base of structure-based design strategy. Biol. evaluation indicated that most of these new compounds could potently inhibit FAK kinase, leading to the promising inhibitors against the proliferation of U-87MG, A-549, and MDA-MB-231 cancer cell lines. Among them, the optimized compound I potently inhibited the enzyme (IC50 = 19.1 nM) and displayed stronger potency than TAE-226 in U-87MG, A-549 and MDA-MB-231 cells, with IC50 values of 0.35, 0.24, and 0.34μM, resp. Compound I is a multi-target kinase inhibitor. Furthermore, compound I also exhibited relatively less cytotoxicity (IC50 = 3.72μM) toward a normal human cell line, HK2. According to the flow cytometry and wound healing assay results, compound I effectively induced apoptosis and G0/G1 phase arrest of MDA-MB-231 cells and suppressed the migration of U-87MG, A-549 and MDA-MB-231 cells. The docking study of compound I was performed to elucidate its possible binding modes and to provide a structural basis for the further structural guidance design of FAK inhibitors. Collectively, these data support the further development of compound I as a lead compound for FAK-targeted anticancer drug discovery.1-Methylpiperazine(cas: 109-01-3Product Details of 109-01-3) was used in this study.

1-Methylpiperazine(cas: 109-01-3) can be used as mimic template in the preparation of molecularly imprinted microspheres (MIMs). It was also used to prepare the difunctional strong anion-exchange stationary phase from a 1,4-diazacyclohexane derivative..Product Details of 109-01-3

Referemce:
Piperazine – Wikipedia,
Piperazines – an overview | ScienceDirect Topics

《A drug-like imidazole-benzothiazole conjugate inhibits malignant melanoma by stabilizing the c-MYC G-quadruplex》 was written by Wu, Tian-Ying; Huang, Qiong; Huang, Zhi-Shu; Hu, Ming-Hao; Tan, Jia-Heng. Product Details of 109-01-3 And the article was included in Bioorganic Chemistry in 2020. The article conveys some information:

Aberrant expression of c-MYC oncogene is significantly associated with the occurrence and development of malignant melanoma. Suppression of the c-MYC transcriptional activity accordingly provides a new idea for treating melanoma. Notably, stabilizing the G-quadruplex (G4) structure in the promoter is proved to be effective in downregulating c-MYC transcription. In this work, we developed a drug-like imidazole-benzothiazole conjugate called IZTZ-1, which was confirmed to preferentially stabilize the promoter G4 and thus lower c-MYC expression. Intracellular assays revealed that IZTZ-1 induced cell cycle arrest, apoptosis, thereby inhibiting cell proliferation. Furthermore, IZTZ-1 was demonstrated to effectively inhibit tumor growth in a melanoma mouse model. Consequently, IZTZ-1 showed good potential in the treatment of melanoma. This study provides an alternative strategy to treat melanoma by targeting the c-MYC G4. After reading the article, we found that the author used 1-Methylpiperazine(cas: 109-01-3Product Details of 109-01-3)

1-Methylpiperazine(cas: 109-01-3) can be used as mimic template in the preparation of molecularly imprinted microspheres (MIMs). It was also used to prepare the difunctional strong anion-exchange stationary phase from a 1,4-diazacyclohexane derivative..Product Details of 109-01-3

Referemce:
Piperazine – Wikipedia,
Piperazines – an overview | ScienceDirect Topics

The author of 《Electrooxidative Amination of sp2 C-H Bonds: Coupling of Amines with Aryl Amides via Copper Catalysis》 were Kathiravan, Subban; Suriyanarayanan, Subramanian; Nicholls, Ian A.. And the article was published in Organic Letters in 2019. Related Products of 109-01-3 The author mentioned the following in the article:

Metal-catalyzed cross-coupling reactions are among the most important transformations in organic synthesis. However, the use of C-H activation for sp2 C-N bond formation remains one of the major challenges in the field of cross-coupling chem. Described herein is the first example of the synergistic combination of copper catalysis and electrocatalysis for aryl C-H amination under mild reaction conditions in an atom-and step-economical manner with the liberation of H2 as the sole and benign byproduct. In addition to this study using 1-Methylpiperazine, there are many other studies that have used 1-Methylpiperazine(cas: 109-01-3Related Products of 109-01-3) was used in this study.

1-Methylpiperazine(cas: 109-01-3) can be used as mimic template in the preparation of molecularly imprinted microspheres (MIMs). It was also used to prepare the difunctional strong anion-exchange stationary phase from a 1,4-diazacyclohexane derivative..Related Products of 109-01-3

Referemce:
Piperazine – Wikipedia,
Piperazines – an overview | ScienceDirect Topics

In 2019,Bioorganic Chemistry included an article by Zhang, Xiaoyu; Song, Qing; Cao, Zhongcheng; Li, Yan; Tian, Chaoquan; Yang, Ziyi; Zhang, Heng; Deng, Yong. Recommanded Product: 109-01-3. The article was titled 《Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer’s disease》. The information in the text is summarized as follows:

A series of chalcone Mannich base derivatives were designed, synthesized and evaluated as multifunctional agents for the treatment of Alzheimer’s disease based on the multi-target directed ligands design strategy. In vitro assays demonstrated that most of the derivatives exerted potent selective inhibitory potency on AChE with good multifunctional properties. Among them, representative compound 7c exhibited moderate inhibitory potency for EeAChE (IC50 = 0.44 μM) and MAO-B inhibition (IC50 = 1.21 μM), good inhibitory effect on self-induced Aβ1-42 aggregation (55.0%, at 25 μM), biometal chelating property, moderate antioxidant activity with a value 1.93-fold of Trolox. Moreover, both kinetic anal. of AChE inhibition and mol. modeling study revealed that 7c showed a mixed-type inhibition, binding simultaneously to CAS and PAS of AChE. In addition, 7c also displayed high BBB permeability. These properties indicated 7c may be a promising multifunctional agent for the treatment of AD. In the experimental materials used by the author, we found 1-Methylpiperazine(cas: 109-01-3Recommanded Product: 109-01-3)

1-Methylpiperazine(cas: 109-01-3) can be used as mimic template in the preparation of molecularly imprinted microspheres (MIMs). It was also used to prepare the difunctional strong anion-exchange stationary phase from a 1,4-diazacyclohexane derivative..Recommanded Product: 109-01-3

Referemce:
Piperazine – Wikipedia,
Piperazines – an overview | ScienceDirect Topics

Ozenil, Marius; Skos, Lukas; Roller, Alexander; Gajic, Natalie; Holzer, Wolfgang; Spreitzer, Helmut; Platzer-Ozenil, Sonja; Vraka, Chrysoula; Hacker, Marcus; Wadsak, Wolfgang; Pichler, Verena published an article in 2021. The article was titled 《Unexpected scaffold rearrangement product of pirenzepine found in commercial samples》, and you may find the article in Scientific Reports.Synthetic Route of C5H12N2 The information in the text is summarized as follows:

Pharmacovigilance aims at a better understanding of the mol. events triggered by medications to prevent adverse effects, which despite significant advances in our anal. repertoire plague the use of drugs until today. In this study, we find that clin. prescribed and com. available pirenzepine may not be the correct compound Pirenzepine can undergo an unexpected scaffold rearrangement from the pharmaceutical active ingredient (API) to a previously uncharacterized benzimidazole. The rearrangement occurs under highly acidic conditions, which were believed to favor the dihydrochloride formation of pirenzepine. The rearranged products of pirenzepine and the structurally related telenzepine have significantly decreased affinity for the muscarinic acetylcholine receptor, the pharmacol. target of these compounds Fortunately, in situ rearrangement after oral application is no safety issue, as we show that reaction kinetics in gastric acid prevent rearrangement. The research community should consider appropriate measures to perform reliable receiving inspections in the com. supply of well described and frequently used chems., in particular if experiments yield unexpected results. After reading the article, we found that the author used 1-Methylpiperazine(cas: 109-01-3Synthetic Route of C5H12N2)

1-Methylpiperazine(cas: 109-01-3) can be used as mimic template in the preparation of molecularly imprinted microspheres (MIMs). It was also used to prepare the difunctional strong anion-exchange stationary phase from a 1,4-diazacyclohexane derivative..Synthetic Route of C5H12N2

Referemce:
Piperazine – Wikipedia,
Piperazines – an overview | ScienceDirect Topics

《Metal-Free Molecular Perovskite High-Energetic Materials》 was written by Shang, Yu; Huang, Rui-Kang; Chen, Shao-Li; He, Chun-Ting; Yu, Zhi-Hong; Ye, Zi-Ming; Zhang, Wei-Xiong; Chen, Xiao-Ming. Quality Control of 1-Methylpiperazine And the article was included in Crystal Growth & Design in 2020. The article conveys some information:

Metal-free energetic materials generally have the advantages of high gas yield and metal-free residue after combustion or explosion, enabling them to be widely used as explosives and propellant components. As part of a series of our investigations on ABX3 mol. perovskite high-energetic materials, here we report five new metal-free members, (H2A)[NH4(ClO4)3], by using different organic cations H2A2+, i.e., 1-hydroxy-1,4-diazabicyclo[2.2.2]octane-1,4-diium for DAP-O4, piperazine-1,4-diium for PAP-4, 1-methyl-piperazine-1,4-diium for PAP-M4, homopiperazine-1,4-diium for PAP-H4, and 1-methyl-1,4-diazabicyclo-[2.2.2]octane-1,4-diium for DAP-M4, resp. Together with the previously reported member, (H2dabco)[NH4(ClO4)3] (DAP-4, H2dabco2+ = 1,4-diazabicyclo[2.2.2]octane-1,4-diium), these six metal-free mol. perovskite high-energetic materials provide nice instances to fine-tune the oxygen balance, crystal d., thermal stability, and detonation performance, by changing the A-site organic cations solely. The d. functional theory (DFT) calculations and the Kamlet-Jacob (K-J) equation suggested that improving the oxygen balance while keeping the spherical shape of the organic cations to match the anionic cage in these metal-free energetic materials facilitates obtaining a better detonation performance, providing an important clue for designing advanced practicable high-energetic materials. It is worth noting that three compounds (PAP-4, PAP-H4, and DAP-O4) are expected to exceed the performances of RDX as both explosive and propellant, in which DAP-O4 has the highest detonation heat (6.21 kJ mol-1), detonation velocity (8.900 km s-1), and detonation pressure (35.7 GPa), as well as a higher specific impulse value (262 s). The oxygen balance, d., thermal stability and detonation performance were fine-tuned by changing A-site organic fuel cations solely in six metal-free mol. perovskite high-energetic materials. In the experiment, the researchers used many compounds, for example, 1-Methylpiperazine(cas: 109-01-3Quality Control of 1-Methylpiperazine)

1-Methylpiperazine(cas: 109-01-3) can be used as mimic template in the preparation of molecularly imprinted microspheres (MIMs). It was also used to prepare the difunctional strong anion-exchange stationary phase from a 1,4-diazacyclohexane derivative..Quality Control of 1-Methylpiperazine

Referemce:
Piperazine – Wikipedia,
Piperazines – an overview | ScienceDirect Topics

《Drug-like biimidazole derivatives dually target c-MYC/BCL-2 G-quadruplexes and inhibit acute myeloid leukemia》 was published in Bioorganic Chemistry in 2020. These research results belong to Hu, Ming-Hao; Yu, Bing-Ying; Wang, Xiaodong; Jin, Guangyi. Formula: C5H12N2 The article mentions the following:

Chemotherapy is the main approach for treating acute myeloid leukemia (AML). However, this therapy can cause severe side effects as well as drug resistance, hence calling for new therapeutic strategies. As c-MYC and BCL-2 are often overexpressed in AML, and synergism between c-MYC and BCL-2 promotes tumorigenesis, therefore, dual targeting of c-MYC/BCL-2 promoter G-quadruplexes (G4s) and then inhibiting the targeted gene expression would be a potential strategy in ALM treatment. In this work, in the search of dual ligands, we performed a screening assay with an inhouse, imidazole-based compound library. Consequently, two drug-like biimidazole derivatives were identified as selective c-MYC/BCL-2 G4 binders, of which, BIM-2 was selected as the candidate for inhibiting AML cell growth. Then, BIM-2 was demonstrated to downregulate both c-MYC and BCL-2 expression, and thereby cause cell cycle arrest at G0/G1 phase and apoptosis in AML cells. Furthermore, the possible end-stacking binding modes between BIM-2 and c-MYC/BCL-2 G4s were revealed by NMR and mol. docking studies. Accordingly, this study provides a new class of drug-like dual-selective c-MYC/BCL-2 G4 ligands for the potential treatment of AML. In the part of experimental materials, we found many familiar compounds, such as 1-Methylpiperazine(cas: 109-01-3Formula: C5H12N2)

1-Methylpiperazine(cas: 109-01-3) can be used as mimic template in the preparation of molecularly imprinted microspheres (MIMs). It was also used to prepare the difunctional strong anion-exchange stationary phase from a 1,4-diazacyclohexane derivative..Formula: C5H12N2

Referemce:
Piperazine – Wikipedia,
Piperazines – an overview | ScienceDirect Topics

The author of 《Development of a FRET-based ratiometric fluorescent probe to monitor the changes in palladium(II) in aqueous solution and living cells》 were Wang, Li; Ren, Mingguang; Li, Zihong; Dai, Lixuan; Lin, Weiying. And the article was published in New Journal of Chemistry in 2019. Formula: C5H12N2 The author mentioned the following in the article:

The enrichment of palladium ions in organisms can harm organisms to a great extent. It is necessary and critical to develop mol. tools that can ratiometrically image Pd2+ in living cells. Herein, we have developed a new FRET-based ratiometric fluorescent probe (CR-Pd, I) for the specific determination of Pd2+ in living cells. Moreover, fluorescence imaging shows that CR-Pd could be used as a probe for the ratiometric visualization of Pd2+ in mitochondria. The results came from multiple reactions, including the reaction of 1-Methylpiperazine(cas: 109-01-3Formula: C5H12N2)

1-Methylpiperazine(cas: 109-01-3) can be used as mimic template in the preparation of molecularly imprinted microspheres (MIMs). It was also used to prepare the difunctional strong anion-exchange stationary phase from a 1,4-diazacyclohexane derivative..Formula: C5H12N2

Referemce:
Piperazine – Wikipedia,
Piperazines – an overview | ScienceDirect Topics

《Synthesis, characterization, and in vivo pharmacological evaluation of novel Mannich bases derived from 1,2,4-triazole containing a naproxen moiety》 was written by Avci, Ahmet; Tasci, Hayrunnisa; Kandemir, Ummuhan; Can, Ozgur Devrim; Gokhan-Kelekci, Nesrin; Tozkoparan, Birsen. Synthetic Route of C5H12N2This research focused ontriazolethione regioselective preparation antinociceptive antiinflammatory mol docking; methoxynaphthylethylmercaptotriazole piperazine Mannich reaction; 1,2,4-Triazole-5-thione N-Mannich derivatives; Anti-inflammatory activity; Antinociceptive activity; Gastric toxicity; Mannich reaction; Naproxen analogs. The article conveys some information:

A new series of 1,2,4-triazole-5-thione Mannich derivatives I (R = Me, 4-fluorophenyl, 4-pyridyl, etc.) containing a naproxen moiety was designed and synthesized to create naproxen analogs, with the aim of developing novel anti-inflammatory/analgesic agents with improved safety profiles. Target compounds were synthesized using classical Mannich reaction (i.e. one-pot three component condensation reaction), by reacting 3-[1-(6-methoxy-2-naphtyl)ethyl]-5-mercapto-1,2,4-triazole, formaldehyde, and diverse secondary amines II in ethanol. Compounds were then evaluated for their potential antinociceptive and anti-inflammatory activities using some validated in vivo methods. Data obtained from acetic acid induced-writhing and carrageenan-induced paw edema tests revealed that all compounds induced peripherally-mediated antinociceptive activities, as well as notable anti-inflammatory effects. The results of hot-plate and tail-clip tests indicated that compounds I (R = Me, Et, 2-fluorophenyl, 4-fluorophenyl, 4-methylphenyl, 4-acetylphenyl) have also centrally-mediated antinociceptive activities in addition to their peripherally-mediated effects. Mol. docking studies were performed to investigate the putative binding modes of the interactions between all compounds and COX-1/COX-2 enzymes using AutoDock Vina software. Docking of the compounds into the COX-2 active site produced binding interactions that are essential for COX-2 inhibitory activity. None of the compounds in the serial, except for I (R = Boc and 4-acetylphenyl), induced significant gastrointestinal irritation. Overall, the results indicated that triazole Mannich bases bearing a naproxen moiety potentially represent a novel class of antinociceptive and anti-inflammatory agent with an improved gastric safety profile. In the experiment, the researchers used many compounds, for example, 1-Methylpiperazine(cas: 109-01-3Synthetic Route of C5H12N2)

1-Methylpiperazine(cas: 109-01-3) can be used as mimic template in the preparation of molecularly imprinted microspheres (MIMs). It was also used to prepare the difunctional strong anion-exchange stationary phase from a 1,4-diazacyclohexane derivative..Synthetic Route of C5H12N2

Referemce:
Piperazine – Wikipedia,
Piperazines – an overview | ScienceDirect Topics

《Design and synthesis of quinoxaline-1,3,4-oxadiazole hybrid derivatives as potent inhibitors of the anti-apoptotic Bcl-2 protein》 was written by Ono, Yukari; Ninomiya, Masayuki; Kaneko, Daiki; Sonawane, Amol D.; Udagawa, Taro; Tanaka, Kaori; Nishina, Atsuyoshi; Koketsu, Mamoru. Quality Control of 1-Methylpiperazine And the article was included in Bioorganic Chemistry in 2020. The article conveys some information:

A series of quinoxaline-1,3,4-oxadiazole hybrids I [R = chloro, Ph, 4-methylpiperazin-1-yl, 4-phenylpiperazin-1-yl, etc.; R1 = hydroxy, amino, 2-phenylethoxy, etc.] were synthesized and assessed for their anticancer potential on human leukemia HL-60 cells. Although these hybrids I exerted significant inhibition of HL-60 cell proliferation, they showed high cytotoxicity on human normal cells (WI-38). Utilizing information from mol. modeling of the hybrids I to the anti-apoptotic Bcl-2 protein, substructures including Ph, piperazine, piperidine and morpholine rings were added to their frameworks. The designed compounds I successfully induced apoptotic response on HL-60 cells with low toxicity on WI-38 cells. Furthermore, RT-PCR anal. demonstrated that these compounds I predominantly inhibited Bcl-2 expression. These findings highlight the great potential for the development of synthetic quinoxaline-1,3,4-oxadiazole hybrid derivatives as proapoptotic anticancer agents. In the experiment, the researchers used 1-Methylpiperazine(cas: 109-01-3Quality Control of 1-Methylpiperazine)

1-Methylpiperazine(cas: 109-01-3) can be used as mimic template in the preparation of molecularly imprinted microspheres (MIMs). It was also used to prepare the difunctional strong anion-exchange stationary phase from a 1,4-diazacyclohexane derivative..Quality Control of 1-Methylpiperazine

Referemce:
Piperazine – Wikipedia,
Piperazines – an overview | ScienceDirect Topics